id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-330877-nsx4b4rm	Elcioglu, Omer Celal	COVİD-19 infection in a membranous nephropathy patient treated with rituximab	2020-09-04		.txt	text/plain	2090	140	52	In this period, one of our group of patients who are challenging us for follow-up and treatment are those who should start or continue to use immunosuppressive therapy. In order to contribute to the accumulation of knowledge in this area, we wanted to report a patient who was followed up with the diagnosis of COVID-19 and had been administered rituximab very recently due to a nephrotic syndrome caused by membranous nephropathy. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related coronavirus disease-19 (COVID19) cases, which emerged in Wuhan [1] , China in December 2019 and soon became a pandemic [2] , started to appear in our country in March 2020. A 48-year old male who was admitted to the emergency clinic with cough, high fever and headache for 4 days was hospitalized on March 15, 2020 with a pre-diagnosis of COVID 19 pneumonia.	./cache/cord-330877-nsx4b4rm.txt	./txt/cord-330877-nsx4b4rm.txt